New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


JPM Day 3: AbbVie Sees Bright Future Ahead, vTv, Gritstone and Achilles

Since acquiring Allergan for $63 billion in 2019, AbbVie said it’s “tracking well” against the financial commitment the company made when striking the deal. Chief Financial Officer Rob Michael said at the 2022 J.P. Morgan Healthcare Conference the company is exceeding AbbVie’s revenue expectations in the aesthetics market, led by Botox.